Clinical trials retrospective studies. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases39

Postoperative Complications Neoplasms Recurrence Disease Progression Breast Neoplasms Neoplasm Recurrence, Local Acute Disease Lung Neoplasms Chronic Disease HIV Infections Stroke Dog Diseases Pain Neoplasm Metastasis Drug-Related Side Effects and Adverse Reactions Adenocarcinoma Intraoperative Complications Colorectal Neoplasms Lymphatic Metastasis Wounds and Injuries Prostatic Neoplasms Myocardial Infarction Brain Neoplasms Kidney Failure, Chronic Carcinoma, Squamous Cell Surgical Wound Infection Liver Neoplasms Hemorrhage Melanoma Critical Illness Cardiovascular Diseases Carcinoma, Non-Small-Cell Lung Bacteremia Diabetes Mellitus, Type 2 Heart Failure Gingival Diseases Emergencies Postoperative Hemorrhage Head and Neck Neoplasms

Chemicals and Drugs24

Antineoplastic Agents Placebos Anti-Bacterial Agents Biological Markers Immunosuppressive Agents Drugs, Investigational Antibodies, Monoclonal, Humanized Drug Combinations Antibodies, Monoclonal Anticoagulants Adrenal Cortex Hormones Tumor Markers, Biological Cyclophosphamide Cisplatin Anti-HIV Agents Fluorouracil Prednisone Methotrexate Doxorubicin Antihypertensive Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypoglycemic Agents Immunologic Factors Anti-Inflammatory Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment118

Retrospective Studies Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Follow-Up Studies Clinical Trials, Phase I as Topic Research Design Controlled Clinical Trials as Topic Double-Blind Method Risk Factors Prognosis Patient Selection Randomized Controlled Trials as Topic Survival Rate Prospective Studies Survival Analysis Cohort Studies Incidence Multicenter Studies as Topic Severity of Illness Index Combined Modality Therapy Clinical Protocols Drug Therapy, Combination Risk Assessment Placebos Drug Administration Schedule Neoplasm Staging Kaplan-Meier Estimate Clinical Trials, Phase IV as Topic Reproducibility of Results Predictive Value of Tests Length of Stay Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Sensitivity and Specificity Multivariate Analysis Single-Blind Method Chi-Square Distribution Early Termination of Clinical Trials Tomography, X-Ray Computed Pilot Projects Questionnaires Logistic Models Prevalence Statistics, Nonparametric Hospitalization Proportional Hazards Models Sample Size Feasibility Studies Treatment Failure Administration, Oral Pain Measurement Reoperation Medical Records Endpoint Determination Pregnancy Outcome Chemotherapy, Adjuvant Magnetic Resonance Imaging Analysis of Variance Biopsy Odds Ratio Regression Analysis Data Interpretation, Statistical Drug Evaluation Visual Acuity Infusions, Intravenous Registries Risk Hospital Mortality Case-Control Studies Probability Remission Induction Preoperative Care Cross-Over Studies Confidence Intervals Laparoscopy Longitudinal Studies Postoperative Care Postoperative Period Statistics as Topic Drug Approval Exercise Therapy Fracture Fixation, Internal Meta-Analysis as Topic Random Allocation Stents Therapeutic Human Experimentation Prosthesis Design Intensive Care Radiotherapy, Adjuvant Drug Monitoring Cross-Sectional Studies Linear Models Blood Transfusion ROC Curve Endoscopy Mass Screening Epidemiologic Methods Models, Statistical Data Collection Diagnostic Errors Pregnancy Rate Palliative Care Orthopedic Procedures Cause of Death Phytotherapy Respiration, Artificial Range of Motion, Articular Observer Variation Salvage Therapy Evaluation Studies as Topic Kidney Transplantation Drug Therapy Immunohistochemistry Disability Evaluation Drug Substitution Decompression, Surgical

Psychiatry and Psychology4

Patient Compliance Visual Acuity Pain Cognitive Therapy

Phenomena and Processes16

Time Factors Pregnancy Sensitivity and Specificity Chi-Square Distribution Dose-Response Relationship, Drug Pregnancy Outcome Recovery of Function Odds Ratio Visual Acuity Pain Risk Probability Gestational Age Algorithms Pregnancy Rate Range of Motion, Articular

Disciplines and Occupations8

Research Design Outcome Assessment (Health Care)Evidence-Based Medicine Biomedical Research Medical Oncology Statistics as Topic Therapeutic Human Experimentation Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena9

Quality of Life Age Distribution Informed Consent Sex Distribution Drug Approval United States Food and Drug Administration Patient Education as Topic National Cancer Institute (U.S.)National Institutes of Health (U.S.)

Technology, Industry, Agriculture2

Dietary Supplements Drug Industry

Humanities1

Quality of Life

Information Science14

Survival Rate Incidence Questionnaires Prevalence Medical Records Data Interpretation, Statistical Databases, Factual Registries Hospital Mortality Algorithms Data Collection Pregnancy Rate Publishing Cause of Death

Named Groups3

Infant, Newborn Research Subjects Patient Dropouts

Health Care112

Retrospective Studies Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Follow-Up Studies Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Double-Blind Method Risk Factors Patient Selection Randomized Controlled Trials as Topic Survival Rate Prospective Studies Survival Analysis Cohort Studies Incidence Multicenter Studies as Topic Severity of Illness Index Clinical Protocols Age Factors Risk Assessment Clinical Trials Data Monitoring Committees Outcome Assessment (Health Care)Kaplan-Meier Estimate Clinical Trials, Phase IV as Topic Reproducibility of Results Predictive Value of Tests Length of Stay Disease-Free Survival Sensitivity and Specificity Multivariate Analysis Single-Blind Method Chi-Square Distribution Early Termination of Clinical Trials Pilot Projects Questionnaires Logistic Models Cost-Benefit Analysis Prevalence Statistics, Nonparametric Hospitalization Proportional Hazards Models Patient Compliance Sample Size Feasibility Studies Treatment Failure Hospitals, University Medical Records Comorbidity Analysis of Variance Sex Factors Odds Ratio Age Distribution Practice Guidelines as Topic Regression Analysis Data Interpretation, Statistical Tertiary Care Centers Patient Satisfaction Hospitals, Teaching Informed Consent Registries Placebo Effect Intensive Care Units Risk Hospital Mortality Health Care Costs Case-Control Studies Probability Patient Participation Sex Distribution Bias (Epidemiology)Preoperative Care Medical Audit Cross-Over Studies Confidence Intervals Safety Referral and Consultation Longitudinal Studies Postoperative Care Postoperative Period Statistics as Topic Guidelines as Topic Emergency Service, Hospital Meta-Analysis as Topic Random Allocation United States Food and Drug Administration Intention to Treat Analysis Intensive Care Patient Education as Topic Cross-Sectional Studies Linear Models ROC Curve Mass Screening Epidemiologic Methods Models, Statistical Data Collection Cancer Care Facilities Physician's Practice Patterns Diagnostic Errors Pregnancy Rate Palliative Care Guideline Adherence Cause of Death Costs and Cost Analysis Observer Variation Evaluation Studies as Topic Research Support as Topic Emergencies Drug Substitution National Cancer Institute (U.S.)National Institutes of Health (U.S.)

Geographicals18

United States France Hong Kong India Great Britain Brazil Japan Germany Italy England Romania Europe China Malaysia Canada Netherlands Nigeria Turkey

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Retrospective Studies Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Time Factors Follow-Up Studies Clinical Trials, Phase I as Topic Research Design Controlled Clinical Trials as Topic Double-Blind Method Risk Factors Prognosis Patient Selection Randomized Controlled Trials as Topic Survival Rate Prospective Studies Survival Analysis Cohort Studies Postoperative Complications Incidence Multicenter Studies as Topic Severity of Illness Index Neoplasms Infant, Newborn Recurrence Combined Modality Therapy Clinical Protocols Drug Therapy, Combination Age Factors Risk Assessment Antineoplastic Agents Placebos Pregnancy Clinical Trials Data Monitoring Committees United States Outcome Assessment (Health Care)Drug Administration Schedule Neoplasm Staging Kaplan-Meier Estimate Clinical Trials, Phase IV as Topic Reproducibility of Results Predictive Value of Tests Length of Stay Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Sensitivity and Specificity Multivariate Analysis Single-Blind Method Chi-Square Distribution Disease Progression Breast Neoplasms Early Termination of Clinical Trials Tomography, X-Ray Computed Neoplasm Recurrence, Local Pilot Projects Quality of Life Questionnaires Logistic Models Cost-Benefit Analysis Prevalence Statistics, Nonparametric Hospitalization Proportional Hazards Models Acute Disease Evidence-Based Medicine Patient Compliance Sample Size Anti-Bacterial Agents Feasibility Studies Treatment Failure Dose-Response Relationship, Drug Lung Neoplasms Administration, Oral Pain Measurement Hospitals, University Chronic Disease HIV Infections Research Subjects Stroke France Reoperation Medical Records Endpoint Determination Pregnancy Outcome Chemotherapy, Adjuvant Biological Markers Comorbidity Magnetic Resonance Imaging Recovery of Function Analysis of Variance Sex Factors Biopsy Hong Kong India Odds Ratio Age Distribution Practice Guidelines as Topic Regression Analysis Data Interpretation, Statistical

No FAQ available that match "clinical trials retrospective studies"